Folic acid supplementation: what is new? Fetal, obstetric, long-term benefits and risks

Folic acid supplementation: what is new? Fetal, obstetric, long-term benefits and risks

The association between folic acid supplementation, prior to conception and/or during pregnancy and pregnancy outcomes, has been the subject of numerous studies. The worldwide recommendation of folic acid is at least 0.4 mg daily for all women of reproductive age, and 4-5 mg in high-risk women. In a...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Future science OA 2016-06, Vol.2 (2), p.FSO116-FSO116
Hauptverfasser: Moussa, Hind N, Hosseini Nasab, Susan, Haidar, Ziad A, Blackwell, Sean C, Sibai, Baha M
Format: Artikel
Sprache:eng
Schlagworte:
adverse pregnancy outcomes
folic acid
pre-conception supplement
Review
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page FSO116
container_issue 2
container_start_page FSO116
container_title Future science OA
container_volume 2
creator Moussa, Hind N
Hosseini Nasab, Susan
Haidar, Ziad A
Blackwell, Sean C
Sibai, Baha M
description The association between folic acid supplementation, prior to conception and/or during pregnancy and pregnancy outcomes, has been the subject of numerous studies. The worldwide recommendation of folic acid is at least 0.4 mg daily for all women of reproductive age, and 4-5 mg in high-risk women. In addition, evidence shows that folic acid supplementation could modulate other adverse pregnancy outcomes, specifically, in pregnancies complicated by seizure disorders, preeclampsia, anemia, fetal growth restriction and autism. This review summarizes the available national and international guidelines, concerning the indications and dosage of folic acid supplementation during pregnancy. In addition, it describes the potential preventive benefits of folic acid supplementation on multiple maternal and fetal outcomes, as well as potential risks.
doi_str_mv 10.4155/fsoa-2015-0015
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5137972</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1854108169</sourcerecordid><originalsourceid>FETCH-LOGICAL-c507t-218aa53c58fd6a2865ba669972e9ada3ca34a001a41166f5fe621674bbf07373</originalsourceid><addsrcrecordid>eNp1kUtv1TAQhS0EolXpliXykkVT_IidpAsQqriAVIlNJZbWxBm3hsS-2E4r_j2ObqnKgo3tkb85czSHkNecnbdcqXcuR2gE46ph9XhGjgVTulFayOdP3kfkNOcfbEO00KJ_SY5EzyQftDwm33dx9paC9RPN634_44KhQPExXND7WyjUZxrw_gPdYYH5jMYxFyzJ2zM6x3DTFEwLHTGg8yVTCBNNPv_Mr8gLB3PG04f7hFzvPl1ffmmuvn3-evnxqrGKdaURvAdQ0qreTRpEr9UIWg9DJ3CACaQF2UJ1Di3nWjvlUAuuu3YcHetkJ0_I-4Psfh0XnGz1nmA2--QXSL9NBG_-_Qn-1tzEO6O47OqUKvD2QSDFXyvmYhafLc4zBIxrNrxXLWc910NFzw-oTTHnhO5xDGdmy8NseZgtD7Mtuza8eWruEf-7_QpcHAC3ljVhth6DRXOoaoe3PuD_1P8A7xibQw</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1854108169</pqid></control><display><type>article</type><title>Folic acid supplementation: what is new? Fetal, obstetric, long-term benefits and risks</title><source>Taylor &amp; Francis Open Access</source><source>DOAJ Directory of Open Access Journals</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>PubMed Central</source><source>PubMed Central Open Access</source><creator>Moussa, Hind N ; Hosseini Nasab, Susan ; Haidar, Ziad A ; Blackwell, Sean C ; Sibai, Baha M</creator><creatorcontrib>Moussa, Hind N ; Hosseini Nasab, Susan ; Haidar, Ziad A ; Blackwell, Sean C ; Sibai, Baha M</creatorcontrib><description>The association between folic acid supplementation, prior to conception and/or during pregnancy and pregnancy outcomes, has been the subject of numerous studies. The worldwide recommendation of folic acid is at least 0.4 mg daily for all women of reproductive age, and 4-5 mg in high-risk women. In addition, evidence shows that folic acid supplementation could modulate other adverse pregnancy outcomes, specifically, in pregnancies complicated by seizure disorders, preeclampsia, anemia, fetal growth restriction and autism. This review summarizes the available national and international guidelines, concerning the indications and dosage of folic acid supplementation during pregnancy. In addition, it describes the potential preventive benefits of folic acid supplementation on multiple maternal and fetal outcomes, as well as potential risks.</description><identifier>ISSN: 2056-5623</identifier><identifier>EISSN: 2056-5623</identifier><identifier>DOI: 10.4155/fsoa-2015-0015</identifier><identifier>PMID: 28031963</identifier><language>eng</language><publisher>England: Future Science Ltd</publisher><subject>adverse pregnancy outcomes ; folic acid ; pre-conception supplement ; Review</subject><ispartof>Future science OA, 2016-06, Vol.2 (2), p.FSO116-FSO116</ispartof><rights>Hind Moussa</rights><rights>Hind Moussa Hind Moussa</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c507t-218aa53c58fd6a2865ba669972e9ada3ca34a001a41166f5fe621674bbf07373</citedby><cites>FETCH-LOGICAL-c507t-218aa53c58fd6a2865ba669972e9ada3ca34a001a41166f5fe621674bbf07373</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC5137972/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC5137972/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,723,776,780,860,881,27903,27904,53769,53771</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/28031963$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Moussa, Hind N</creatorcontrib><creatorcontrib>Hosseini Nasab, Susan</creatorcontrib><creatorcontrib>Haidar, Ziad A</creatorcontrib><creatorcontrib>Blackwell, Sean C</creatorcontrib><creatorcontrib>Sibai, Baha M</creatorcontrib><title>Folic acid supplementation: what is new? Fetal, obstetric, long-term benefits and risks</title><title>Future science OA</title><addtitle>Future Sci OA</addtitle><description>The association between folic acid supplementation, prior to conception and/or during pregnancy and pregnancy outcomes, has been the subject of numerous studies. The worldwide recommendation of folic acid is at least 0.4 mg daily for all women of reproductive age, and 4-5 mg in high-risk women. In addition, evidence shows that folic acid supplementation could modulate other adverse pregnancy outcomes, specifically, in pregnancies complicated by seizure disorders, preeclampsia, anemia, fetal growth restriction and autism. This review summarizes the available national and international guidelines, concerning the indications and dosage of folic acid supplementation during pregnancy. In addition, it describes the potential preventive benefits of folic acid supplementation on multiple maternal and fetal outcomes, as well as potential risks.</description><subject>adverse pregnancy outcomes</subject><subject>folic acid</subject><subject>pre-conception supplement</subject><subject>Review</subject><issn>2056-5623</issn><issn>2056-5623</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2016</creationdate><recordtype>article</recordtype><recordid>eNp1kUtv1TAQhS0EolXpliXykkVT_IidpAsQqriAVIlNJZbWxBm3hsS-2E4r_j2ObqnKgo3tkb85czSHkNecnbdcqXcuR2gE46ph9XhGjgVTulFayOdP3kfkNOcfbEO00KJ_SY5EzyQftDwm33dx9paC9RPN634_44KhQPExXND7WyjUZxrw_gPdYYH5jMYxFyzJ2zM6x3DTFEwLHTGg8yVTCBNNPv_Mr8gLB3PG04f7hFzvPl1ffmmuvn3-evnxqrGKdaURvAdQ0qreTRpEr9UIWg9DJ3CACaQF2UJ1Di3nWjvlUAuuu3YcHetkJ0_I-4Psfh0XnGz1nmA2--QXSL9NBG_-_Qn-1tzEO6O47OqUKvD2QSDFXyvmYhafLc4zBIxrNrxXLWc910NFzw-oTTHnhO5xDGdmy8NseZgtD7Mtuza8eWruEf-7_QpcHAC3ljVhth6DRXOoaoe3PuD_1P8A7xibQw</recordid><startdate>20160601</startdate><enddate>20160601</enddate><creator>Moussa, Hind N</creator><creator>Hosseini Nasab, Susan</creator><creator>Haidar, Ziad A</creator><creator>Blackwell, Sean C</creator><creator>Sibai, Baha M</creator><general>Future Science Ltd</general><scope>FUSOA</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20160601</creationdate><title>Folic acid supplementation: what is new? Fetal, obstetric, long-term benefits and risks</title><author>Moussa, Hind N ; Hosseini Nasab, Susan ; Haidar, Ziad A ; Blackwell, Sean C ; Sibai, Baha M</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c507t-218aa53c58fd6a2865ba669972e9ada3ca34a001a41166f5fe621674bbf07373</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2016</creationdate><topic>adverse pregnancy outcomes</topic><topic>folic acid</topic><topic>pre-conception supplement</topic><topic>Review</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Moussa, Hind N</creatorcontrib><creatorcontrib>Hosseini Nasab, Susan</creatorcontrib><creatorcontrib>Haidar, Ziad A</creatorcontrib><creatorcontrib>Blackwell, Sean C</creatorcontrib><creatorcontrib>Sibai, Baha M</creatorcontrib><collection>Future Science (Open Access)</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Future science OA</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Moussa, Hind N</au><au>Hosseini Nasab, Susan</au><au>Haidar, Ziad A</au><au>Blackwell, Sean C</au><au>Sibai, Baha M</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Folic acid supplementation: what is new? Fetal, obstetric, long-term benefits and risks</atitle><jtitle>Future science OA</jtitle><addtitle>Future Sci OA</addtitle><date>2016-06-01</date><risdate>2016</risdate><volume>2</volume><issue>2</issue><spage>FSO116</spage><epage>FSO116</epage><pages>FSO116-FSO116</pages><issn>2056-5623</issn><eissn>2056-5623</eissn><abstract>The association between folic acid supplementation, prior to conception and/or during pregnancy and pregnancy outcomes, has been the subject of numerous studies. The worldwide recommendation of folic acid is at least 0.4 mg daily for all women of reproductive age, and 4-5 mg in high-risk women. In addition, evidence shows that folic acid supplementation could modulate other adverse pregnancy outcomes, specifically, in pregnancies complicated by seizure disorders, preeclampsia, anemia, fetal growth restriction and autism. This review summarizes the available national and international guidelines, concerning the indications and dosage of folic acid supplementation during pregnancy. In addition, it describes the potential preventive benefits of folic acid supplementation on multiple maternal and fetal outcomes, as well as potential risks.</abstract><cop>England</cop><pub>Future Science Ltd</pub><pmid>28031963</pmid><doi>10.4155/fsoa-2015-0015</doi><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 2056-5623
ispartof Future science OA, 2016-06, Vol.2 (2), p.FSO116-FSO116
issn 2056-5623
2056-5623
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5137972
source Taylor & Francis Open Access; DOAJ Directory of Open Access Journals; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; PubMed Central; PubMed Central Open Access
subjects adverse pregnancy outcomes
folic acid
pre-conception supplement
Review
title Folic acid supplementation: what is new? Fetal, obstetric, long-term benefits and risks
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-27T10%3A26%3A32IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Folic%20acid%20supplementation:%20what%20is%20new?%20Fetal,%20obstetric,%20long-term%20benefits%20and%20risks&rft.jtitle=Future%20science%20OA&rft.au=Moussa,%20Hind%20N&rft.date=2016-06-01&rft.volume=2&rft.issue=2&rft.spage=FSO116&rft.epage=FSO116&rft.pages=FSO116-FSO116&rft.issn=2056-5623&rft.eissn=2056-5623&rft_id=info:doi/10.4155/fsoa-2015-0015&rft_dat=%3Cproquest_pubme%3E1854108169%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1854108169&rft_id=info:pmid/28031963&rfr_iscdi=true